Trevi Therapeutics Inc (TRVI)’s stock has witnessed a price declined of -0.66% from the previous close with its current price standing at $10.41. Its current price is -27.65% under its 52-week high of $14.39 and 199.91% more than its 52-week low of $3.47.
TRVI’s price to book ratio for the most recent quarter was 7.03, resulting in an 6.85 price to cash per share for the period.
How does Trevi Therapeutics Inc (TRVI) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Trevi Therapeutics Inc (TRVI): Earnings History
If we examine Trevi Therapeutics Inc’s recent earnings history, in the last quarter ended on 9/30/2025, it posted adjusted earnings per share of -$0.08, slashing the consensus of -$0.1. In other words, it beat the consensus by $0.02, resulting in a 20.99% surprise. In the 3 months period before the previous quarter which was closed on 9/30/2025, the stock recorded adjusted earnings per share of -$0.08 in contrast with the Outlook of -$0.1. That was a difference of $0.02 and a surprise of 20.99%.
Trevi Therapeutics Inc (NASDAQ: TRVI) Ownership Details
I will give a breakdown of the key shareholders in Trevi Therapeutics Inc (TRVI). Recent figures show that the company’s insiders hold 0.68% of shares. A total of 223 institutional investors hold shares in the company, making 103.80% of its stock and 104.52% of its float.
Sep 30, 2025, it was reported that the Company’s largest institutional holder is NEA Management Company, LLC holding total of 13.22 shares that make 10.31% of the company’s total number of shares and are currently priced at 138.04 million.
The securities firm Frazier Life Sciences Management, L.P. holds 10.26 shares of TRVI, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 8.00%, and the holding percentage of shares is valued at 107.11 million.
